MicroPort Scientific Corporation (MSK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, MicroPort Scientific Corporation (MSK) has a cash flow conversion efficiency ratio of -0.053x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-81.89 Million ≈ $-95.74 Million USD) by net assets (€1.54 Billion ≈ $1.80 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MSK defensive interval ratio to measure how many days the company can operate on defensive assets alone.
MicroPort Scientific Corporation - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how MicroPort Scientific Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data.
MicroPort Scientific Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MicroPort Scientific Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Abcellera Biologics Inc
NASDAQ:ABCL
|
-0.036x |
|
Shipping Corporation Of India Limited
NSE:SCI
|
0.085x |
|
Jinzhou Jixiang Molybdenum Co Ltd
SHG:603399
|
-0.010x |
|
Realia
MC:RLIA
|
0.038x |
|
Galapagos N.V.
AS:GLPG
|
-0.024x |
|
China Railway Construction Corporation Limited
F:4FF
|
0.045x |
|
Taiji Computer Corp Ltd
SHE:002368
|
0.046x |
|
Anupam Rasayan India Limited
NSE:ANURAS
|
0.012x |
Annual Cash Flow Conversion Efficiency for MicroPort Scientific Corporation (2013–2025)
The table below shows the annual cash flow conversion efficiency of MicroPort Scientific Corporation from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see MSK company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €1.50 Billion ≈ $1.75 Billion |
€69.13 Million ≈ $80.82 Million |
0.046x | +206.22% |
| 2024-12-31 | €1.14 Billion ≈ $1.34 Billion |
€-49.67 Million ≈ $-58.07 Million |
-0.043x | +73.75% |
| 2023-12-31 | €1.40 Billion ≈ $1.64 Billion |
€-231.87 Million ≈ $-271.08 Million |
-0.165x | +13.70% |
| 2022-12-31 | €1.79 Billion ≈ $2.10 Billion |
€-343.30 Million ≈ $-401.36 Million |
-0.192x | -64.90% |
| 2021-12-31 | €2.22 Billion ≈ $2.59 Billion |
€-257.53 Million ≈ $-301.08 Million |
-0.116x | -594.78% |
| 2020-12-31 | €1.39 Billion ≈ $1.62 Billion |
€-23.20 Million ≈ $-27.12 Million |
-0.017x | -141.33% |
| 2019-12-31 | €653.97 Million ≈ $764.55 Million |
€26.45 Million ≈ $30.92 Million |
0.040x | -74.57% |
| 2018-12-31 | €528.95 Million ≈ $618.39 Million |
€84.13 Million ≈ $98.36 Million |
0.159x | -28.08% |
| 2017-12-31 | €439.45 Million ≈ $513.77 Million |
€97.19 Million ≈ $113.62 Million |
0.221x | -7.16% |
| 2016-12-31 | €346.48 Million ≈ $405.07 Million |
€82.53 Million ≈ $96.49 Million |
0.238x | +146.45% |
| 2015-12-31 | €317.83 Million ≈ $371.57 Million |
€30.72 Million ≈ $35.91 Million |
0.097x | +86.59% |
| 2014-12-31 | €343.74 Million ≈ $401.87 Million |
€17.81 Million ≈ $20.82 Million |
0.052x | -64.98% |
| 2013-12-31 | €390.43 Million ≈ $456.46 Million |
€57.75 Million ≈ $67.52 Million |
0.148x | -- |
About MicroPort Scientific Corporation
MicroPort Scientific Corporation, together with its subsidiaries, engages in the innovating, manufacturing, and marketing medical devices globally in the People's Republic of China, the United States of America, Europe, Middle East and Africa, Japan, and internationally. The company's Cardiovascular Devices segment offers medical solutions for the treatment of coronary artery-related diseases; an… Read more